Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Prepaid Assets came in at $10.4 million in Q1 2026, down 24.23% year-on-year from $13.8 million in Q1 2025, and down 8.53% quarter-over-quarter from $11.4 million in Q4 2025.
Zentalis Pharmaceuticals has reported Prepaid Assets for 8 years, with the latest figure at $10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 24.23% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (down 24.23% YoY), and the FY2025 full-year result was $11.4 million, down 20.79% from the prior year.
- Prepaid Assets for Q1 2026 stood at $10.4 million, down from $11.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $24.3 million in Q2 2022, with the low at $7.6 million in Q3 2025.
- Average Prepaid Assets over 5 years is $14.6 million, with a median of $13.8 million recorded in 2025.
- Year-over-year, Prepaid Assets soared 193.25% in 2022 and tumbled 48.08% in 2023.
- Tracing ZNTL's Prepaid Assets over 5 years: stood at $14.6 million in 2022, then jumped by 41.58% to $20.6 million in 2023, then sank by 30.16% to $14.4 million in 2024, then slipped by 20.79% to $11.4 million in 2025, then declined by 8.53% to $10.4 million in 2026.
- The last three Prepaid Assets figures came in at $10.4 million (Q1 2026), $11.4 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.43 Mn |
| Dec 31, 2025 | 11.41 Mn |
| Sep 30, 2025 | 7.61 Mn |
| Jun 30, 2025 | 11.39 Mn |
| Mar 31, 2025 | 13.77 Mn |
| Dec 31, 2024 | 14.40 Mn |
| Sep 30, 2024 | 9.02 Mn |
| Jun 30, 2024 | 13.23 Mn |
| Mar 31, 2024 | 14.82 Mn |
| Dec 31, 2023 | 20.62 Mn |
| Sep 30, 2023 | 11.63 Mn |
| Jun 30, 2023 | 18.86 Mn |
| Mar 31, 2023 | 17.71 Mn |
| Dec 31, 2022 | 14.56 Mn |
| Sep 30, 2022 | 22.40 Mn |
| Jun 30, 2022 | 24.34 Mn |
| Mar 31, 2022 | 11.67 Mn |
| Dec 31, 2021 | 10.64 Mn |
| Sep 30, 2021 | 16.47 Mn |
| Jun 30, 2021 | 8.30 Mn |
| Mar 31, 2021 | 10.52 Mn |
| Dec 31, 2020 | 6.18 Mn |
| Sep 30, 2020 | 5.18 Mn |
| Jun 30, 2020 | 5.22 Mn |
| Mar 31, 2020 | 2.22 Mn |
| Dec 31, 2019 | 1.51 Mn |